Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 3/2008

01.03.2008 | Original Article

Comparison of oocyte quality and intracytoplasmic sperm injection outcome in women with isolated polycystic ovaries or polycystic ovarian syndrome

verfasst von: Banchhita Sahu, Ozkan Ozturk, Massimo Ranierri, Paul Serhal

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 3/2008

Einloggen, um Zugang zu erhalten

Abstract

Objective

To compare the oocyte quality and intracytoplasmic sperm injection performance in women with isolated polycystic ovaries or polycystic ovarian syndrome.

Design

Retrospective study.

Setting

Fertility unit.

Population

Three study groups were identified: women with PCO-only morphology (50 cycles), PCOS (51 cycles) and age matched control group (104 cycles) with isolated male factor infertility necessitating ICSI.

Method

Controlled ovarian hyperstimulation and ICSI.

Main outcome measures

Response to gonadotropin stimulation, oocyte and embryo quality, clinical pregnancy rate and pregnancy outcome.

Results

Despite a significantly lower total gonadotropin dose, a significantly higher serum E2 level was attained in both the PCOS and the PCO-only groups compared to the control group. Although significantly more oocytes were retrieved in the PCOS and PCO-only groups, the number of 2-pronuclear embryos was similar to controls. No significant differences were noted in the maturity of the oocytes, oocyte dysmorphism, embryo quality, implantation and pregnancy rates among the three groups. However the clinical miscarriage rate was significantly lower in women with PCO-only morphology group (15.4 versus 31%, P < 0.05) than in the PCOS group.

Conclusion

Women with PCO-only appearance have shown to have similar characteristics to women with PCOS in terms of ovarian response to hMG stimulation, oocyte and embryo quality and pregnancy rates. However miscarriage rates were significantly lower in the PCO-only group than the PCOS group. Our findings suggest that factors unrelated to oocyte and embryo morphology present in PCOS patients may be instrumental in adverse reproductive outcomes in these women.
Literatur
1.
Zurück zum Zitat Jacobs HS (1987) Polycystic ovaries and polycystic ovary syndrome. Gynecol Endocrinol 1:113–131PubMedCrossRef Jacobs HS (1987) Polycystic ovaries and polycystic ovary syndrome. Gynecol Endocrinol 1:113–131PubMedCrossRef
2.
3.
Zurück zum Zitat Engmann L, Maconochie N, Sladkevicius P, Bekir J, Campbell S, Tan SL (1999) The outcome of in-vitro fertilization treatment in women with sonographic evidence of polycystic ovarian morphology. Hum Reprod 14:167–71PubMedCrossRef Engmann L, Maconochie N, Sladkevicius P, Bekir J, Campbell S, Tan SL (1999) The outcome of in-vitro fertilization treatment in women with sonographic evidence of polycystic ovarian morphology. Hum Reprod 14:167–71PubMedCrossRef
4.
Zurück zum Zitat Ludwig M, Finas DF, al-Hasani S, Diedrich K, Ortmann O (1999) Oocyte quality and treatment outcome in intracytoplasmic sperm injection cycles of polycystic ovarian syndrome patients. Hum Reprod 14:354–358PubMedCrossRef Ludwig M, Finas DF, al-Hasani S, Diedrich K, Ortmann O (1999) Oocyte quality and treatment outcome in intracytoplasmic sperm injection cycles of polycystic ovarian syndrome patients. Hum Reprod 14:354–358PubMedCrossRef
5.
Zurück zum Zitat Mulders AG, Laven JS, Imani B, Eijkemans MJ, Fauser BC (2003) IVF outcome in anovulatory infertility (WHO group 2)—including polycystic ovary syndrome—following previous unsuccessful ovulation induction. Reprod Biomed Online 7:50–58PubMed Mulders AG, Laven JS, Imani B, Eijkemans MJ, Fauser BC (2003) IVF outcome in anovulatory infertility (WHO group 2)—including polycystic ovary syndrome—following previous unsuccessful ovulation induction. Reprod Biomed Online 7:50–58PubMed
6.
Zurück zum Zitat Heijnen EM, Ejjkemans MJ, Hughes EG, Laven JS, Macklon NS, Fauser BC (2006) A meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome. Hum Reprod 12:13–21 Heijnen EM, Ejjkemans MJ, Hughes EG, Laven JS, Macklon NS, Fauser BC (2006) A meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome. Hum Reprod 12:13–21
7.
Zurück zum Zitat The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19:41–47CrossRef The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19:41–47CrossRef
8.
Zurück zum Zitat Balen AH, Laven JS, Tan SL, Dewailly D (2003) Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum Reprod Update 9:505–514PubMedCrossRef Balen AH, Laven JS, Tan SL, Dewailly D (2003) Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum Reprod Update 9:505–514PubMedCrossRef
9.
Zurück zum Zitat Muttukrishna S, McGarrigle H, Wakim R, Khadum I, Ranieri DM, Serhal P (2005) Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology? BJOG 112:1384–1390PubMedCrossRef Muttukrishna S, McGarrigle H, Wakim R, Khadum I, Ranieri DM, Serhal P (2005) Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology? BJOG 112:1384–1390PubMedCrossRef
10.
Zurück zum Zitat Van Steirteghem AC, Nagy Z, Joris H (1993) High fertilization and implantation rate after ICSI. Hum Reprod 8:1061–1066PubMed Van Steirteghem AC, Nagy Z, Joris H (1993) High fertilization and implantation rate after ICSI. Hum Reprod 8:1061–1066PubMed
11.
Zurück zum Zitat Desai NN, Goldstein J, Rowland DY, Goldfarb JM (2000) Morphological evaluation of human embryos and derivation of an embryo quality scoring system specific for day 3 embryos: a preliminary study. Hum Reprod 15:2190–2196PubMedCrossRef Desai NN, Goldstein J, Rowland DY, Goldfarb JM (2000) Morphological evaluation of human embryos and derivation of an embryo quality scoring system specific for day 3 embryos: a preliminary study. Hum Reprod 15:2190–2196PubMedCrossRef
12.
Zurück zum Zitat Veeck LL, Bodine R, Clarke RN, Berrios R, Libraro J, Moschini RM, Zaninovic N, Rosenwaks Z (2004) High pregnancy rates can be achieved after freezing and thawing human blastocysts. Fertil Steril 82:1418–1427PubMedCrossRef Veeck LL, Bodine R, Clarke RN, Berrios R, Libraro J, Moschini RM, Zaninovic N, Rosenwaks Z (2004) High pregnancy rates can be achieved after freezing and thawing human blastocysts. Fertil Steril 82:1418–1427PubMedCrossRef
13.
Zurück zum Zitat Esinler I, Bayar U, Bozdag G, Yarali H (2005) Outcome of intracytoplasmic sperm injection in patients with polycystic ovary syndrome or isolated polycystic ovaries. Fertil Steril 84:932–937PubMedCrossRef Esinler I, Bayar U, Bozdag G, Yarali H (2005) Outcome of intracytoplasmic sperm injection in patients with polycystic ovary syndrome or isolated polycystic ovaries. Fertil Steril 84:932–937PubMedCrossRef
14.
Zurück zum Zitat Ebner T (2006) Is oocyte morphology prognostic of embryo developmental potential after ICSI? Reprod BioMed Online 12:507–512PubMed Ebner T (2006) Is oocyte morphology prognostic of embryo developmental potential after ICSI? Reprod BioMed Online 12:507–512PubMed
15.
Zurück zum Zitat Kahraman S, Yakin K, Dönmez E et al. (2000) Relationship between granular cytoplasm of oocytes and pregnancy outcome following intracytoplasmic sperm injection. Hum Reprod 15:2390–2393PubMedCrossRef Kahraman S, Yakin K, Dönmez E et al. (2000) Relationship between granular cytoplasm of oocytes and pregnancy outcome following intracytoplasmic sperm injection. Hum Reprod 15:2390–2393PubMedCrossRef
16.
Zurück zum Zitat Ebner T, Sommergruber M, Moser M, Sheb O, Schreier-Lechner E, Tews G (2006) Basal level of anti-Müllerian hormone is associated with oocyte quality in stimulated cycles. Hum Reprod 21:2022–2026PubMedCrossRef Ebner T, Sommergruber M, Moser M, Sheb O, Schreier-Lechner E, Tews G (2006) Basal level of anti-Müllerian hormone is associated with oocyte quality in stimulated cycles. Hum Reprod 21:2022–2026PubMedCrossRef
17.
Zurück zum Zitat Otsuki J, Okada A, Morimoto K et al (2004) The relationship between pregnancy outcome and smooth endoplasmic reticulum clusters in MII human oocytes. Hum Reprod 19:1591–1597PubMedCrossRef Otsuki J, Okada A, Morimoto K et al (2004) The relationship between pregnancy outcome and smooth endoplasmic reticulum clusters in MII human oocytes. Hum Reprod 19:1591–1597PubMedCrossRef
18.
Zurück zum Zitat Hardy K, Robinson FM, Paraschos T, Wicks R, Franks S, Winston RM (1995) Normal development and metabolic activity of preimplantation embryos in vitro from patients with polycystic ovaries. Hum Reprod 10:2125–2135PubMed Hardy K, Robinson FM, Paraschos T, Wicks R, Franks S, Winston RM (1995) Normal development and metabolic activity of preimplantation embryos in vitro from patients with polycystic ovaries. Hum Reprod 10:2125–2135PubMed
19.
Zurück zum Zitat Norman RJ, Davies MJ, Lord J, Moran LJ (2002) The role of lifestyle modification in polycystic ovary syndrome. Trends Endocrinol Metab 13:251–257PubMedCrossRef Norman RJ, Davies MJ, Lord J, Moran LJ (2002) The role of lifestyle modification in polycystic ovary syndrome. Trends Endocrinol Metab 13:251–257PubMedCrossRef
20.
Zurück zum Zitat Regan L, Owen EJ, Jacobs HS (1990) Hypersecretion of luteinising hormone, infertility, and miscarriage. Lancet 336:1141–1144PubMedCrossRef Regan L, Owen EJ, Jacobs HS (1990) Hypersecretion of luteinising hormone, infertility, and miscarriage. Lancet 336:1141–1144PubMedCrossRef
21.
Zurück zum Zitat Balen AH, Tan SL, MacDougall J, Jacobs S (1993) Miscarraige rates following in vitro fertilization are increased in women with polycystic ovaries and reduced by pituitary desinsitisation with buserelin. Hum Reprod 8:959–964PubMed Balen AH, Tan SL, MacDougall J, Jacobs S (1993) Miscarraige rates following in vitro fertilization are increased in women with polycystic ovaries and reduced by pituitary desinsitisation with buserelin. Hum Reprod 8:959–964PubMed
22.
Zurück zum Zitat Homburg R, Lewy T, Berkovitz D et al (1993) Gonadotropin releasing harmone antagonist reduces the miscarriage rate for pregnancy achieved in women with polycystic ovarian syndrome. Fertil Steril 59:527–531PubMed Homburg R, Lewy T, Berkovitz D et al (1993) Gonadotropin releasing harmone antagonist reduces the miscarriage rate for pregnancy achieved in women with polycystic ovarian syndrome. Fertil Steril 59:527–531PubMed
23.
Zurück zum Zitat Rai R, Backos M, Rushworth F, Regan L (2000) Polycystic ovaries and recurrent miscarriage—a reappraisal. Hum Reprod 15:612–615PubMedCrossRef Rai R, Backos M, Rushworth F, Regan L (2000) Polycystic ovaries and recurrent miscarriage—a reappraisal. Hum Reprod 15:612–615PubMedCrossRef
24.
Zurück zum Zitat Franks S, Roberts R, Hardy K (2003) Gonadotrophin regimens and oocyte quality in women with polycystic ovaries. Reprod Biomed Online 6:181–184PubMedCrossRef Franks S, Roberts R, Hardy K (2003) Gonadotrophin regimens and oocyte quality in women with polycystic ovaries. Reprod Biomed Online 6:181–184PubMedCrossRef
25.
Zurück zum Zitat Mikkelsen AL, Lindenberg S (2001) Morphology of in-vitro matured oocytes: impact on fertility potential and embryo quality. Hum Reprod 16:1714–1718PubMedCrossRef Mikkelsen AL, Lindenberg S (2001) Morphology of in-vitro matured oocytes: impact on fertility potential and embryo quality. Hum Reprod 16:1714–1718PubMedCrossRef
Metadaten
Titel
Comparison of oocyte quality and intracytoplasmic sperm injection outcome in women with isolated polycystic ovaries or polycystic ovarian syndrome
verfasst von
Banchhita Sahu
Ozkan Ozturk
Massimo Ranierri
Paul Serhal
Publikationsdatum
01.03.2008
Verlag
Springer-Verlag
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 3/2008
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-007-0462-x

Weitere Artikel der Ausgabe 3/2008

Archives of Gynecology and Obstetrics 3/2008 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.